Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pain, Postoperative 3Prostatic Neoplasms 2Neoplasms 2Myofibroma 2Lung Neoplasms 2Breast Neoplasms 2Uterine Neoplasms 1Supratentorial Neoplasms 1Sexual Dysfunction, Physiological 1Scleroderma, Localized 1Rectal Neoplasms 1Pain 1Neurofibromatoses 1Neurodermatitis 1Neuralgia 1Mastodynia 1Lichen Planus 1Leukemia-Lymphoma 1Leiomyoma 1Kidney Neoplasms 1Keratosis, Actinic 1Keratoacanthoma 1Keloid 1Ileus 1Hydrocephalus 1Hordeolum 1Headache 1Granuloma Annulare 1Eyelid Neoplasms 1Epilepsy 1

Interventions

perampanel 1clevidipine 1Sevoflurane 1Propofol 1Nitrous Oxide 1Lidocaine 1Levetiracetam 1Glycopyrrolate 1Dexmedetomidine 1Anticonvulsants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Epilepsy × Lidocaine × Clear all
NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡